Published in Cancer Res on May 01, 1974
'Green revolution' genes encode mutant gibberellin response modulators. Nature (1999) 8.87
The Arabidopsis GAI gene defines a signaling pathway that negatively regulates gibberellin responses. Genes Dev (1997) 7.30
LNCaP model of human prostatic carcinoma. Cancer Res (1983) 7.23
Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer (1980) 3.37
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med (1993) 3.37
Purification of a human prostate specific antigen. Invest Urol (1979) 3.11
The LNCaP cell line--a new model for studies on human prostatic carcinoma. Prog Clin Biol Res (1980) 2.97
Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet (1986) 2.78
Carcinoembryonic antigen in patients with different cancers. JAMA (1972) 2.56
Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin (1993) 2.43
The journal "impact factor": a misnamed, misleading, misused measure. Cancer Genet Cytogenet (1998) 2.23
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer (1998) 2.15
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology (1998) 2.04
American Joint Committee on Cancer prognostic factors consensus conference. Cancer (1999) 2.02
Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer (1999) 1.99
Culture of human leukemia cells. Cancer (1966) 1.94
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res (1988) 1.91
Disappearance of a structural chromatin protein A24 in mitosis: implications for molecular basis of chromatin condensation. Proc Natl Acad Sci U S A (1979) 1.91
SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature (1971) 1.77
Race-related differences in breast cancer patients. Results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer (1985) 1.76
Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer (1981) 1.73
Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate (1999) 1.71
Characterization of a new primary human pancreatic tumor line. Cancer Invest (1986) 1.67
Secondary carcinomas of the kidney. J Urol (1975) 1.59
The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer (1999) 1.58
Clinical highlights from the National Cancer Data Base: 1994. CA Cancer J Clin (1994) 1.58
The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet (1984) 1.54
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). II. Biomarker studies. Cancer (1985) 1.51
Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet (1986) 1.49
Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli. J Gen Microbiol (1992) 1.48
Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource. Cancer (1985) 1.48
The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment. Cancer (1997) 1.47
Isopeptidase: a novel eukaryotic enzyme that cleaves isopeptide bonds. Proc Natl Acad Sci U S A (1982) 1.47
Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer (1994) 1.46
Convention on nomenclature for DNA cytometry. Committee on Nomenclature, Society for Analytical Cytology. Cancer Genet Cytogenet (1984) 1.42
The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer (1991) 1.39
Trisomy 14: a new entity within acute nonlymphocytic leukemia. Cancer Genet Cytogenet (1989) 1.39
Involvement of 6p in benign lipomas. A new cytogenetic entity? Cancer Genet Cytogenet (1989) 1.39
Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer (1988) 1.35
CEA as a monitor of gastrointestinal malignancy. Cancer (1975) 1.33
CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. J Surg Oncol (1998) 1.29
Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons. J Urol (1986) 1.29
Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons. Ann Surg (1980) 1.27
Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer. Cancer (1993) 1.27
Hybridization of nuclear matrix attached deoxyribonucleic acid fragments. Biochemistry (1981) 1.26
Translocation X;18 in synovial sarcoma. Cancer Genet Cytogenet (1986) 1.26
The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer (1996) 1.25
Clonal chromosomal abnormalities in desmoid tumors. Implications for histopathogenesis. Cancer (1992) 1.23
The association of benign prostatic hyperplasia and cancer of the prostate. Cancer (1992) 1.22
Cytogenetic studies of tumor tissue from patients with nonfamilial renal cell carcinoma. Cancer Res (1986) 1.22
Quantitative conservation of chromatin-bound RNA polymerases I and II in mitosis. Implications for chromosome structure. J Cell Biol (1979) 1.20
Involvement of chromosome X in primary cytogenetic change in human neoplasia: nonrandom translocation in synovial sarcoma. Proc Natl Acad Sci U S A (1987) 1.20
Cytogenetic studies of adipose tissue tumors. II. Recurrent reciprocal translocation t(12;16)(q13;p11) in myxoid liposarcomas. Cancer Genet Cytogenet (1986) 1.19
The chromosomes and causation of human cancer and leukemia. Cancer Res (1966) 1.19
Cytogenetic findings in liposarcoma correlate with histopathologic subtypes. Cancer (1992) 1.18
Prostate antigen: a new potential marker for prostatic cancer. Prostate (1981) 1.18
Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients. Prostate Suppl (1996) 1.17
Increased sister chromatid exchange in bone marrow and blood cells from Bloom's syndrome. Cytogenet Cell Genet (1976) 1.17
Induction of prophase in interphase nuclei by fusion with metaphase cells. J Cell Biol (1972) 1.16
The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer (1996) 1.13
Correlations of the orthogonal electrocardiogram and vectorcardiogram with consitutional variables in 518 normal men. Circulation (1967) 1.12
Steroid receptors in exocrine glands: the pancreas and prostate. J Steroid Biochem (1979) 1.12
Follow-up evaluation of a phase II prostate cancer vaccine trial. Prostate (1999) 1.11
Three possible cytogenetic subgroups of leiomyosarcoma. Cancer Genet Cytogenet (1989) 1.11
Chromosomal abnormalities in human neoplasia. Annu Rev Med (1970) 1.10
Use of human prostate-specific antigen in monitoring prostate cancer. Cancer Res (1981) 1.10
A murine renal cell carcinoma. J Natl Cancer Inst (1973) 1.09
Why is the prostate cancer death rate declining in the United States? Cancer (1998) 1.09
Chromosome pulverization in human binucleate cells following colcemid treatment. J Cell Biol (1967) 1.09
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. Prostate (1998) 1.09
A prostate antigen in sera of prostatic cancer patients. Cancer Res (1980) 1.08
BCL3 rearrangements and t(14;19) in chronic lymphocytic leukemia and other B-cell malignancies: a molecular and cytogenetic study. Genes Chromosomes Cancer (1997) 1.08
Matrix metalloproteinase homologues from Arabidopsis thaliana. Expression and activity. J Biol Chem (1999) 1.07
Chromosomal abnormalities in leiomyosarcomas. Am J Pathol (1993) 1.07
Management and survival of carcinoma of the colon: results of a national survey by the American College of Surgeons. Ann Surg (1978) 1.07
Chromosomes and causation of human cancer and leukemia: XL. The Ph1 and other translocations in CML. Cancer (1980) 1.07
Chromosomes and causation of human cancer and leukemia. II. Karyotypes of human solid tumors. Cancer (1966) 1.07
Cytogenetic characterization of putative human myeloblastic leukemia cell lines (ML-1, -2, and -3): origin of the cells. Cancer Res (1986) 1.06
Cytogenetic analysis of dermatofibrosarcoma protuberans. Cancer Genet Cytogenet (1990) 1.06
Prostate cancer: progress and change. CA Cancer J Clin (1978) 1.06
The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer. Cancer (1979) 1.05
Elevated superoxide dismutase in Bloom's syndrome: a genetic condition of oxidative stress. Cancer Res (1989) 1.05
Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides. Prostate (1997) 1.05
A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program. Cancer (1997) 1.05
Chronology and pattern of human chromosome replication, IV. Autoradiographic studies of binucleate cells. Proc Natl Acad Sci U S A (1966) 1.05
Sex chromosome aneuploidy and aging. Mutat Res (1995) 1.05
Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA Cancer J Clin (1993) 1.05
Translocation (X;1) in papillary renal cell carcinoma. A new cytogenetic subtype. Cancer Genet Cytogenet (1993) 1.05
Prostate-specific membrane antigen: current and future utility. Semin Urol Oncol (1998) 1.04
Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res (1980) 1.04
The National Cancer Data Base report on longitudinal observations on prostate cancer. Cancer (1996) 1.04
Prostate-specific antigen levels in young white and black men 20 to 45 years old. Urology (2000) 1.04
Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system. Cancer Res (1982) 1.04
The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol (1982) 1.04
American Cancer Society guideline for the early detection of prostate cancer: update 1997. CA Cancer J Clin (1997) 1.04
Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04
Method for identifying prostate cells in semen using flow cytometry. Prostate (1998) 1.04